Welcome to the fourth season of the Psychedelic Invest Podcast! It’s great to be back! On the season premiere episode, host Bruce Eckfeldt is joined...
A new study in rodents shows that low doses of psilocybin increase resilience to stress and lowers compulsive actions. The post New Study Shows Microdoses...
Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE:7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development...
MindBio Therapeutics Corp. have started selection of participants for its Phase 2 randomized double-blind and placebo controlled clinical trial in advanced...
Ride this wave if you dare. Tidal Wave mushrooms are said to be one of the most potent trips out there. But just how strong are...
–Abstract entitled, “Structure-activity of 2C-X psychedelics to develop a novel 5-HT2A receptor full agonist with therapeutic potential” – –...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
As the psychedelic space expands rapidly and exponentially, there is a dire need for infrastructure to support the needs of the industry. Psychedelics...
A new study published in the New England Journal of Medicine found that Spravato’s esketamine was more effective than a commonly prescribed drug in treating...
The 60-year effort to legalize psychedelics in California has nearly come to an end, but it still has one more hurdle to overcome. SB58 is a...